Document is current

Any future updates will be listed below

Safety, efficacy, and cardiovascular benefits of combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists in patients with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1186/s13098-025-01635-6

Published Online: 2025-02-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark